Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia

被引:8
作者
Kashimura, Makoto [1 ]
Ohyashiki, Kazuma [2 ]
机构
[1] Matsudo City Hosp, Dept Hematol, Chiba 2718511, Japan
[2] Tokyo Med Univ, Dept Internal Med 1, Div Hematol, Tokyo, Japan
关键词
QUIESCENT; CELLS; PML;
D O I
10.1016/j.leukres.2010.02.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E213 / E214
页数:2
相关论文
共 5 条
[1]  
BACCARANI M, 2009, NET J CLIN ONCOL, V27, P6041
[2]   Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro [J].
Graham, SM ;
Jorgensen, HG ;
Allan, E ;
Pearson, C ;
Alcorn, MJ ;
Richmond, L ;
Holyoake, TL .
BLOOD, 2002, 99 (01) :319-325
[3]   PML targeting eradicates quiescent leukaemia-initiating cells [J].
Ito, Keisuke ;
Bernardi, Rosa ;
Morotti, Alessandro ;
Matsuoka, Sahoko ;
Saglio, Giuseppe ;
Ikeda, Yasuo ;
Rosenblatt, Jacalyn ;
Avigan, David E. ;
Teruya-Feldstein, Julie ;
Pandolfi, Pier Paolo .
NATURE, 2008, 453 (7198) :1072-U4
[4]   Arsenic degrades PML or PML - RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway [J].
Lallemand-Breitenbach, Valerie ;
Jeanne, Marion ;
Benhenda, Shirine ;
Nasr, Rihab ;
Lei, Ming ;
Peres, Laurent ;
Zhou, Jun ;
Zhu, Jun ;
Raught, Brian ;
de The, Hugues .
NATURE CELL BIOLOGY, 2008, 10 (05) :547-555
[5]   A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia [J].
Zhang, Qun-Ye ;
Mao, Jian-Hua ;
Liu, Ping ;
Huang, Qiu-Hua ;
Lu, Jing ;
Xie, Yin-Yin ;
Weng, Lin ;
Zhang, Yan ;
Chen, Quan ;
Chen, Sai-Juan ;
Chen, Zhu .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (09) :3378-3383